Spineguard raised €8.1 million in Successful IPO (on NYSE Alternext), for growth, expansion and development

Home > MEMBER NEWS  > Spineguard raised €8.1 million in Successful IPO (on NYSE Alternext), for growth, expansion and development

Congratulations to new CEO-CF member Pierre Jérôme with SpineGuard. Based on an initial stock price of €7.29 per share, the company now has a post-IPO market capitalization of €31.4 million ($40.8 million). 

 

“We are delighted to announce today the success of SpineGuard’s IPO on Alternext despite particularly difficult financial market conditions,” said Pierre Jérôme (Spineguard CEO/co-founder). “This IPO represents a major step for the company in establishing the PediGuard device as a standard of care in pedicle screw placement at the very moment we have reached the milestone of 25,000 surgeries. We warmly thank all our new shareholders joining us today, our historical shareholders who have supported us for the past four years, our employees in the USA and France and our partners worldwide without whom we would not have reached this milestone. With the raised funds, we will be able to accelerate our commercial expansion and the development of our platform technology.”
 
For more info, please click here